tisseel s/d lösung für gewebekleber; lösung für gewebekleber
baxter - human-fibrinogen; faktor xiii; human-thrombin; aprotinin; calcium-chlorid dihydrat - lösung für gewebekleber; lösung für gewebekleber - 4 ml - human-fibrinogen ; faktor xiii ; human-thrombin ; aprotinin ; calcium-chlorid dihydrat - combinations
tisseel s/d lösung für gewebekleber; lösung für gewebekleber
baxter - human-fibrinogen; faktor xiii; human-thrombin; aprotinin; calcium-chlorid dihydrat - lösung für gewebekleber; lösung für gewebekleber - 10 ml - human-fibrinogen ; faktor xiii ; human-thrombin ; aprotinin ; calcium-chlorid dihydrat - combinations
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinale stromatumoren - andere antineoplastische wirkstoffe, die protein-kinase-inhibitoren - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.
minocyclin-ratiopharm 50 mg hartkapseln
ratiopharm gmbh (3087881) - minocyclinhydrochlorid ((wasserfrei, nicht arzneibuch-konform)) - hartkapsel - teil 1 - hartkapsel; minocyclinhydrochlorid ((wasserfrei, nicht arzneibuch-konform)) (06217) 54 milligramm
sertralin hexal 100 mg filmtabletten
h e x a l aktiengesellschaft (3079284) - sertralinhydrochlorid - filmtablette - sertralinhydrochlorid (22354) 111,9 milligramm
captopril abz 50 mg tabletten
abz-pharma gmbh - geschäftsanschrift - (4238075) - captopril - tablette - teil 1 - tablette; captopril (19545) 50 milligramm
sempera
janssen-cilag gmbh (8009839) - itraconazol - kapsel - itraconazol (23401) 100 milligramm
cardioxane 500 mg, pulver zur herstellung einer infusionslösung
clinigen healthcare b.v. (8181225) - dexrazoxan - pulver zur herstellung einer infusionslösung - teil 1 - pulver zur herstellung einer infusionslösung; dexrazoxan (26073) 500 milligramm
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastische mittel - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.